• Insmed Chief Medical Officer Martina Flammer reported option exercises and stock sales dated July 6.
• Exercised options for 12,302 shares at USD 29.13 and USD 19.74.
• Sold 12,302 shares at weighted average prices of USD 109.02 and USD 110.6.
• Beneficial ownership in common stock stood at 60,486 shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Insmed Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001796960-26-000018), on July 08, 2026, and is solely responsible for the information contained therein.